Soligenix Inc (SNGX)
0.4045
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.3992
-0.01
(-1.31%)
After-Hours: 20:00
Soligenix Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 32.07% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -84.43% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -266.9% |
| December 31, 2020 | 15.49% |
| September 30, 2020 | 23.77% |
| June 30, 2020 | -24.24% |
| March 31, 2020 | 1.86% |
| December 31, 2019 | -3.34% |
| September 30, 2019 | -1.95% |
| June 30, 2019 | -2.44% |
| March 31, 2019 | -45.09% |
| December 31, 2018 | -17.41% |
| September 30, 2018 | -16.24% |
| June 30, 2018 | -9.22% |
| March 31, 2018 | -25.94% |
| December 31, 2017 | -3.80% |
| September 30, 2017 | -5.66% |
| June 30, 2017 | 31.67% |
| March 31, 2017 | 18.30% |
| December 31, 2016 | 27.66% |
| Date | Value |
|---|---|
| September 30, 2016 | 11.12% |
| June 30, 2016 | 25.87% |
| March 31, 2016 | 15.15% |
| December 31, 2015 | 16.33% |
| September 30, 2015 | 21.36% |
| June 30, 2015 | 25.74% |
| March 31, 2015 | 35.39% |
| December 31, 2014 | 20.02% |
| September 30, 2014 | 24.33% |
| June 30, 2014 | 27.05% |
| March 31, 2014 | 30.93% |
| December 31, 2013 | 25.54% |
| September 30, 2013 | 21.32% |
| June 30, 2013 | 16.50% |
| March 31, 2013 | 17.40% |
| December 31, 2012 | 17.96% |
| September 30, 2012 | 18.25% |
| June 30, 2012 | 19.21% |
| March 31, 2012 | 14.03% |
| December 31, 2011 | 15.87% |
| September 30, 2011 | 88.70% |
| June 30, 2011 | 13.88% |
| March 31, 2011 | 31.43% |
| December 31, 2010 | 23.00% |
| September 30, 2010 | 9.43% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-266.9%
Minimum
Mar 2021
32.07%
Maximum
Dec 2022
-31.01%
Average
-2.20%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Eagle Pharmaceuticals Inc | -- |
| Marinus Pharmaceuticals Inc | 87.66% |
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |